Clinical Trial Update: Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA) [Phase 4]

View source ↗

Summary

Pfizer's long-term Phase 4 study of Genotropin (somatropin) in children with short stature born small for gestational age (SGA) has completed and results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Stature

Drugs mentioned

• GENOTROPIN (SOMATROPIN)

Snippet

Sponsor: Pfizer | Conditions: Short Stature Born Small for Gestational Age (SGA) | Phase 4 | Status: COMPLETED | Results posted: 2016-03-15